Skip to Content

LDT (Tyzeka 600 mg)

Generic Name: telbivudine

Pill with imprint LDT is White, Elliptical / Oval and has been identified as Tyzeka 600 mg. It is supplied by Novartis Corporation.

Tyzeka is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Tyzeka 600 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LDT

Tyzeka

Generic Name:
telbivudine
Imprint:
LDT
Strength:
600 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Corporation
National Drug Code (NDC):
00078-0538

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide